Inspiro Medical Ltd.

www.inspiromedical.com

High-Tech Company

Acquired by OPKO Health

Graduated from: Trendlines Incubators

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, MedTech, Respiratory

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2010
Number of Employees	3
Reg. Number:	abCDe

DESCRIPTION

Inspiro Medical is dedicated to the development of a global inhalation platform designed to deliver both small molecules such as corticosteroids or beta agonists and macromolecules such as antibodies or vaccines. The company completed successful FIM clinical trials with asthmatic children using Inspiromatic, its proprietary dry powder inhaler.

TECHNOLOGY

Inspiro’s proprietary inhaler is the first device to combine an active dry powder fluidization mechanism that works with low inhalation flow rates with a unique realtime feedback control and data logger that indicates proper inhalation technique and followup.

Products and Phases

Product	Phase
Inspiromatic	Phase I
Inspiromatic leverages the advantages of existing aerosol delivery devices while improving on current drawbacks. Inspiro’s proprietary inhaler, Inspiromatic(TM), is the first device to combine dry powder with an easy to wear face mask or mouthpiece, making for exponentially improved drug delivery. The company’s novel dry powder inhaler (DPI), designed for single-use drug capsules, detects and fluidizes the powder according to the patient’s inhalation ability and breathing pattern and does not rely on rapid and forceful inhalation. Inspiro’s device provides a controlled powder fluidization method that offers the appropriate powder quantity, at an optimal flow, at the right time - resulting in highly efficient delivery of medication.

	TARGET MARKETS
	Individuals suffering from Asthma and other breathing related conditions, Pharma companies looking for advanced DPI delivery devices.

	BUSINESS MODEL
	B2B2C

CONTACT INFO

Expand / Collapse All

Main Address: Misgav, Israel

Address	17 Techelet St., Misgav Business Park
POB	20174
City	Misgav
Country	Israel
Zip	2017900

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Nimrod Kaufmann	Co-Founder
Dr. Guy Steuer	Co-Founder

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Apr. 18, 2014

R&D

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Feb. 15, 2011

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Investor	abCDe
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Feb. 15, 2011

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe	R&D grant ($0.51m)

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Dec. 01, 2010

Seed

Contributor	Type	Amount	Remarks
abC Defghij	Technology Transfer Company	abCDe

Last Updated:	abCDe
IVC Number:	abCDe